BioTheryX is a clinical-stage biopharmaceutical company that discovers, develops and commercializes targeted protein degradation therapies for cancer, inflammatory and immunological diseases.
September 2018Reported4BioTheryX, Inc. Announces the Appointment of BioPharma Finance Veteran Peter N. Crnkovich to Board of Directorsprnewswire.com5BioTheryX, Inc. Announces the Appointment of BioPharma Finance Veteran Peter N. Crnkovich to Board of Directorsbiotheryx.com
Role or object indicated by the source: “Senior Consultant”.
November 11, 2019Reported4BioTheryX, Inc. Announces the Appointment of BioPharma Finance Veteran Peter N. Crnkovich to Board of Directorsprnewswire.com5BioTheryX, Inc. Announces the Appointment of BioPharma Finance Veteran Peter N. Crnkovich to Board of Directorsbiotheryx.com
Function or object indicated by the source: “Board of Directors”.